occlusive arterial disease

occlusive arterial disease

limb artery occlusion, due to progressive atherosclerosis and/or thrombosis, leading ultimately to distal tissue infarction
References in periodicals archive ?
8, 2014 /PRNewswire/ -- Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, "Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014" provides data on the Occlusive Arterial Disease (OAD) clinical trial scenario.
Contract award: study 2012-07 (gcp) clinical practice guidelines for the diagnosis and treatment of occlusive arterial disease of the legs.
Testing for venous thrombosis and occlusive arterial disease are the subjects of Chapters 9 and 10.
The ABI, a noninvasive method to assess the patency of the lower extremity arterial system and to detect occlusive arterial disease (7), was measured in every patient.
The company's other products include the Duett(TM) sealing device to rapidly seal the puncture site following catheterization procedures, the D-Stat(R) Flowable hemostat which is used in a wide variety of interventional procedures for the local management of active bleeding, and the Acolysis(R) intravascular therapeutic ultrasound product which is sold in international markets for the treatment of peripheral occlusive arterial disease.
A significant reduction in first major vascular events (major coronary, strokes, and revascularizations) was seen with simvastatin in patients with no diagnosed occlusive arterial disease at study entry.
In April 2002 the company acquired the Acolysis intravascular therapeutic ultrasound product which is sold in international markets for the treatment of peripheral occlusive arterial disease.
MST-188 - Occlusive Arterial Disease In 2014, the Company achieved several milestones related to its clinical-stage program in occlusive arterial disease, including:
1c] was measured in fresh whole blood, collected from 360 individuals with evidence of occlusive arterial disease and/or diabetes mellitus (2), by HPLC using a Biomen Hi-Autolc HA-8121 analyzer and reagents and a calibrator linked to Biomen reference values.
The Company's other products include the Duett(TM) sealing device to rapidly seal the puncture site following catheterization procedures, the D-Stat(R) Flowable hemostat for the local management of active bleeding, and the Acolysis(R) intravascular therapeutic ultrasound product which is sold in international markets for the treatment of peripheral occlusive arterial disease.